Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Vivimed Labs Share Price

Q: What is the current share price of Vivimed Labs Ltd.?

As of 9 April 2026 at 10:26 AM, the share price for Vivimed Labs Ltd. is ₹ 7.01 on the NSE and ₹ 6.1100001 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Vivimed Labs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 9 April 2026, the market cap for Vivimed Labs Ltd. is approximately ₹ 58.1 Cr.

Q: What are the PE and PB ratios for Vivimed Labs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Vivimed Labs Ltd. is -1.7, and the Price-to-Book (PB) ratio is -0.8.

Q: What is the 52-Week High and Low for Vivimed Labs Ltd.?

Over the past 52 weeks, the highest price reached by Vivimed Labs Ltd. shares was ₹ 29.4, and the lowest price was ₹ 5.15.

Q: Who are the major shareholders of Vivimed Labs Ltd.?

Significant shareholdings in Vivimed Labs Ltd. typically include entities such as: Public Promoter FII Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Vivimed Labs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Vivimed Labs Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Corona Remedies for analysis and benchmarking.

Q: What is the latest dividend information for Vivimed Labs Ltd.?

Vivimed Labs Ltd. last declared a FINAL dividend of ₹ 0.4 per share for the financial period ending 2018. The record date was set as 2018-09-19, and the payment was/is scheduled around 2018-09-19. For the most current dividend announcements, refer to official company filings.

Vivimed Labs Ltd.

₹7.01

0.33(4.94%)

Trade Now

9th Apr 2026 | 3:11 PM

NSE : VIVIMEDLAB

Open Free Demat Account

Vivimed Labs Performance

Price Movement

₹7.01

₹6.71

₹7.01

↘ Today's Low↗ Today's High

1 Year Performance

₹7.01

₹5.15

₹29.40

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹7.01

Low₹6.71

Open at₹6.99

Prev Close₹6.68

Volumes62.78 K

Avg Price₹7.00

Lower Circuit₹6.35

Upper Circuit₹7.01

Historical Performance

3M High₹10.51

3M Low₹5.15

1 Yr High₹29.40

1 Yr Low₹5.15

3 Yr High₹29.40

3 Yr Low₹4.85

5 Yr High₹41.50

5 Yr Low₹4.85

Vivimed Labs Fundamentals

Market Cap

Low in industry

58.10 Cr.

PE Ratio (TTM)

Negative PE TTM

-1.70

Dividend Yield

Net Profit TTM

66% decr over last year

-34.95

Net Profit Growth

66% decr over last year

-34.95

PEG Ratio

Below industry Median

ROE

Operating Revenue TTM

83.60

Operating Revenue Growth

35% decr over last year

Book Value

Negative Price to Book

-0.80

MFI

MFI oversold

20.51

RSI

RSI is mid-range

51.80

EPS (TTM)

-3.85

Debt to Equity

-5.14

Face Value

Operating Profit Margin Qtr.

-10.82

Operating Profit Qtr.

-10.92

Net Profit Qtr.

-16.55

Operating Revenue Qtr.

15.99

PB Ratio

-0.80

Vivimed Labs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	11.63	18.66	17.94	22.58	34.23
Operating Expense	22.85	19.98	18.48	25.06	34.41
Operating Profit	-11.22	-1.32	-0.54	-2.48	-0.18
Depreciation	4.40	4.68	4.80	4.61	6.37
Interest	0.94	1.60	0.52	1.48	0.43
Tax	0	0	0	0	0
Net Profit	-16.57	-7.44	-5.50	-4.42	-6.97

Vivimed Labs Technicals

Vivimed Labs Ltd. EMA & SMA

₹7.01

0.33 (4.94%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹6.2

Day EMA10 ₹6.1

Day EMA12 ₹6.2

Day EMA20 ₹6.3

Day EMA26 ₹6.5

Day EMA50 ₹7.3

Day EMA100 ₹8.4

Day EMA200 ₹9.8

Vivimed Labs Support and Resistance

Resistance

First Resistance₹6.68

Second Resistance₹6.68

Third Resistance₹6.68

Support

First Support₹6.68

Second Support₹6.68

Third Support₹6.68

Technical Indicators

Day RSI51.80

Day MFI20.51

Day ADX24.59

Day Commodity Channel Index52.30

William-1.29

Day MACD-0.38

Day MACD Signal Line-0.50

Day ATR0.38

Day ROC125-47.40

Day ROC21-5.92

Vivimed Labs Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	20.9	20.9	20.9	7.8	7.8	7.8
FII	1.6	1.6	1.6	1.6	1.6	1.6
DII	0.2	0.2	0.2	0.2	0.2	0.2
Public	77.3	77.3	77.3	90.5	90.5	90.5

Vivimed Labs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	42.22 K	43.22 K	97.67%
Week	49.84 K	56.92 K	87.56%
1 Month	1.49 L	1.76 L	84.68%
6 Month	2.05 L	2.82 L	72.78%

Vivimed Labs SWOT Analysis

Strengths12

Weakness12

Opportunity0

Threats0

Positive Breakout Third Resistance ( LTP > R3)

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Stock with Low PE (PE < = 10)

Top Gainers

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Volume Shockers

Vivimed Labs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
19 Sep, 2018	0.4	FINAL	Equity Share
21 Sep, 2017	0.4	FINAL	Equity Share
24 Sep, 2014	3	FINAL	Equity Share
24 Sep, 2013	3	FINAL	Equity Share
21 Sep, 2012	3	FINAL	Equity Share
26 Sep, 2011	2	FINAL	Equity Share
09 Sep, 2010	1.5	FINAL	Equity Share
24 Sep, 2009	1.5	FINAL	Equity Share
22 Sep, 2008	1	FINAL	Equity Share

Vivimed Labs Stock Comparison

Financials	Sai Parenterals Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Senores Pharmaceuticals Ltd.
Price (₹)	₹425	₹105.93	₹122.50	₹530.80	₹803.40
% Change	0.77%	-3.20%	2.60%	-0.52%	2.57%
Revenue TTM (₹ Cr)	-	₹282.74	-	₹488.20	₹588.52
Net Profit TTM (₹ Cr)	-	₹15.30	-	₹56.90	₹101.60
PE TTM	-	26.90	-	27.00	36.50
1 Year Return	7.83	-15.85	33.64	-15.37	54
ROCE	28.91	-	-	23.87	9.34

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 679.95

-0.47%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 57.50

-4.01%

SIGACHI

Sigachi Industries Ltd.

₹ 20.70

-1.29%

WINDLAS

Windlas Biotech Ltd.

₹ 798.00

+1.30%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.15

+2.66%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 480.10

-0.64%

ZIMLAB

Zim Laboratories Ltd.

₹ 70.11

-1.23%

MEDICO

Medico Remedies Ltd.

₹ 38.48

-1.64%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 158.00

-2.48%

LASA

Lasa Supergenerics Ltd.

₹ 7.51

+4.16%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 290.20

-0.90%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 324.90

-0.23%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.80

-4.33%

BROOKS

Brooks Laboratories Ltd.

₹ 71.93

+0.28%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1890.00

+0.93%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 136.13

+10.00%

ALPA

Alpa Laboratories Ltd.

₹ 70.00

-0.34%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 145.72

+7.02%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 415.00

+3.96%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.74

-0.46%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 32.49

+2.91%

INDOCO

Indoco Remedies Ltd.

₹ 202.75

+2.29%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 143.48

-4.52%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 546.00

-1.14%

FAQ's on VIVIMEDLAB

What is the current share price of Vivimed Labs Ltd.?

As of 9 April 2026 at 10:26 AM, the share price for Vivimed Labs Ltd. is ₹ 7.01 on the NSE and ₹ 6.1100001 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Vivimed Labs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 9 April 2026, the market cap for Vivimed Labs Ltd. is approximately ₹ 58.1 Cr.

What are the PE and PB ratios for Vivimed Labs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Vivimed Labs Ltd. is -1.7, and the Price-to-Book (PB) ratio is -0.8.

What is the 52-Week High and Low for Vivimed Labs Ltd.?

Over the past 52 weeks, the highest price reached by Vivimed Labs Ltd. shares was ₹ 29.4, and the lowest price was ₹ 5.15.

Who are the major shareholders of Vivimed Labs Ltd.?

Significant shareholdings in Vivimed Labs Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Vivimed Labs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Vivimed Labs Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Corona Remedies for analysis and benchmarking.

What is the latest dividend information for Vivimed Labs Ltd.?

Vivimed Labs Ltd. last declared a FINAL dividend of ₹ 0.4 per share for the financial period ending 2018. The record date was set as 2018-09-19, and the payment was/is scheduled around 2018-09-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy